Home Cart Sign in  
Chemical Structure| 106308-44-5 Chemical Structure| 106308-44-5

Structure of Rufinamide
CAS No.: 106308-44-5

Chemical Structure| 106308-44-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Rufinamide, an antiepileptic agent, is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).

Synonyms: CGP 33101; E 2080; Inovelon

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Rufinamide

CAS No. :106308-44-5
Formula : C10H8F2N4O
M.W : 238.19
SMILES Code : O=C(C1=CN(CC2=C(F)C=CC=C2F)N=N1)N
Synonyms :
CGP 33101; E 2080; Inovelon
MDL No. :MFCD00865314
InChI Key :POGQSBRIGCQNEG-UHFFFAOYSA-N
Pubchem ID :129228

Safety of Rufinamide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Sodium Channel

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02205931 Epilepsy Phase 4 Recruiting June 2019 United Kingdom ... More >> Birmingham Children's Hospital Recruiting Birmingham, United Kingdom, B4 6NH Contact: Shakti Agrawal, MBBS    0044 1213338149    shakti.agrawal@bch.nhs.uk    Principal Investigator: Shakti Agrawal, MBBS          Bristol Royal Hospital for Children Recruiting Bristol, United Kingdom, BS2 8AE Contact: Andrew Mallick, FRCPCH          Principal Investigator: Andrew Mallick          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Alasdair Parker, MA    0044 1223 245151    alasdair.parker@addenbrookes.nhs.uk    Principal Investigator: Alasdair Parker, MA          Lancashire Teaching Hospitals NHS Foundation Trust Recruiting Lancashire, United Kingdom Contact: Helen Basu       Helen.Basu@lthtr.nhs.uk    Principal Investigator: Helen Basu          Leeds Teaching Hospital Recruiting Leeds, United Kingdom, LS1 3EX Contact: Helen McCullagh, RCPCH    0044 113 243 2799    h.mccullagh@nhs.net    Principal Investigator: Helen McCullagh, RCPCH          Alder Hey Children's Hospital Recruiting Liverpool, United Kingdom, L12 2AP Contact: Rachel Kneen, BMBS    0044 151 2525163    rachel.kneen@liverpool.ac.uk    Principal Investigator: Rachel Kneen, BMBS          Great Ormond Street Hospital Recruiting London, United Kingdom, WC1N 3JH Contact: Christin Eltze, MD Res    0044 207 405 9200 ext 5438    christin.eltze@gosh.nhs.uk    Principal Investigator: Christin Eltze, MD Res          St George's University Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Penny Fallon       Penny.Fallon@stgeorges.nhs.uk    Principal Investigator: Penny Fallon          Royal Manchester Children's Hospital Recruiting Manchester, United Kingdom, M13 0JE Contact: Tim Martland, RCPCH    0044 161 276 1234    timothy.martland@cmft.nhs.uk    Principal Investigator: Tim Martland, RCPCH          The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Contact: Anita Devlin       Anita.Devlin@nuth.nhs.uk    Principal Investigator: Anita Devlin          Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom Contact: Archana Desurkar       Archana.Desurkar@sch.nhs.uk    Principal Investigator: Archana Desurkar Less <<
NCT00552526 Epilepsy Ment... More >>al Retardation Less << Phase 4 Unknown December 2013 Norway ... More >> SSE, Nevrological dep. , Rikshospitalet University hospital Oslo, Norway Less <<
NCT01212458 - Completed - Switzerland ... More >> University Hospital Zurich, Institut of Anaesthesiology Zurich, ZH, Switzerland, 8091 Less <<
NCT01146951 Lennox-Gastaut Syndrome Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Hiroshima-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Kobe-shi, Hyogo, Japan Yokohama-shi, Kanagawa, Japan Goshi-shi, Kumamoto, Japan Iwamuma-shi, Miyagi, Japan Omura-shi, Nagasaki, Japan Nara-shi, Nara, Japan Niigata-shi, Niigata, Japan Yufu-shi, Oita, Japan Okayama-shi, Okayama, Japan Neyagawa-shi, Osaka, Japan Osaka-shi, Osaka, Japan Suita-shi, Osaka, Japan Moriya-shi, Shiga, Japan Shizuoka-shi, Shizuoka, Japan Kodaira-shi, Tokyo, Japan Kokubunji-shi, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toyoma-shi, Toyama, Japan Less <<
NCT01146951 - Completed - -
NCT00595231 Generalized Anxiety Disorder Phase 2 Completed - United States, Georgia ... More >> Carmen Research Atlanta, Georgia, United States, 30080 United States, Ohio Midwest Clinical Research Center Dayton, Ohio, United States, 45408 Less <<
NCT01991041 - Completed - -
NCT02175173 Lennox-Gastaut Syndrome COMPLETED 2022-11-02 Osaka, Japan|Tokyo, Japan
NCT00334958 Epilepsy Phase 3 Completed - -
NCT00448539 Refractory Partial Onset Seizu... More >>res Less << PHASE3 TERMINATED 2010-05-14 University of South Alabama Me... More >>dical Center, Mobile, Alabama, 36693, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Bradenton Research Center, Bradenton, Florida, 34205, United States|University of Florida, The Neuroscience Institute at Shands, Jacksonville, Florida, 32209, United States|Pediatric Neurologists of Palm Beach, Loxahatchee Groves, Florida, 33470, United States|Pediatric Neurosciences, PA, Orlando, Florida, 32835, United States|Bay Medical Center, Panama City, Florida, 32405, United States|Child Neurology Associates, PC, Atlanta, Georgia, 30342, United States|Southern Illinois University Neurology and Pharmacology, Springfield, Illinois, 62794-9643, United States|McFarland Clinic PC, Ames, Iowa, 50010-3014, United States|John Hopkins Hospital, Dept. of Neurology, Baltimore, Maryland, 21287, United States|Hattiesburg Clinic, Hattiesburg, Mississippi, 39401, United States|Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield, Missouri, 63017, United States|Dartmouth Medical School Neuroscience Center, Lebanon, New Hampshire, 03756-0001, United States|Five Towns Neuroscience Research, Cedarhurst, New York, 11516, United States|New York University Medical Centre, Comprehensive Epilepsy Center, New York, New York, 10016, United States|Weill Cornell Medical Center, Comprehensive Epilepsy Center, New York, New York, 10021, United States|Asheville Neurology Specialists, Asheville, North Carolina, 28806, United States|Ohio State University, Columbus, Ohio, 43210, United States|Medical University of Ohio at Toledo - Dept. of Neurology, Toledo, Ohio, United States|Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, 19104-4204, United States|University of Pennsylvania Medical Center-Department of Neurology, Philadelphia, Pennsylvania, 19104-4283, United States|University of Tennessee Health Sciences Center, Dept. of Neurology, Memphis, Tennessee, 38105, United States|Access Clinical Trials, Inc, Nashville, Tennessee, 37203, United States|Neurological Clinic of Texas, P.A., Dallas, Texas, 75230, United States|Texas Tech University Health Sciences Center, Dept. of Neuropsychiatry, El Paso, Texas, 79905, United States|Fletcher Allen Healthcare, Burlington, Vermont, 05401, United States Less <<
NCT01405053 Lennox-Gastaut Syndrome Phase 3 Completed - United States, District of Col... More >>umbia Washington, District of Columbia, United States United States, Florida Tampa, Florida, United States Wellington, Florida, United States United States, Kentucky Lexington, Kentucky, United States United States, Ohio Akron, Ohio, United States Columbus, Ohio, United States United States, Texas San Antonio, Texas, United States United States, Virginia Norfolk, Virginia, United States Canada, Alberta Edmonton, Alberta, Canada France Bron, France Marseille, France Paris, France Greece Pendeli Athens, Greece Thessaloniki, Greece Italy Mantua, MN, Italy Calambrone, PI, Italy Pavia, PV, Italy Roma, RM, Italy Poland Elblag, Poland Gdansk, Poland Kielce, Poland Poznan, Poland Less <<
NCT02095899 Peripheral Nerve Injuries|Pain PHASE2 WITHDRAWN 2025-05-15 University Hospital Zurich, In... More >>stitut of Anaesthesiology, Zurich, ZH, 8091, Switzerland Less <<
NCT02332174 Seizures Phase 1 Completed - -
NCT00334958 - Completed - -
NCT00448539 Refractory Partial Onset Seizu... More >>res Less << PHASE3 TERMINATED 2010-05-14 University of South Alabama Me... More >>dical Center, Mobile, Alabama, 36693, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Bradenton Research Center, Bradenton, Florida, 34205, United States|University of Florida, The Neuroscience Institute at Shands, Jacksonville, Florida, 32209, United States|Pediatric Neurologists of Palm Beach, Loxahatchee Groves, Florida, 33470, United States|Pediatric Neurosciences, PA, Orlando, Florida, 32835, United States|Bay Medical Center, Panama City, Florida, 32405, United States|Child Neurology Associates, PC, Atlanta, Georgia, 30342, United States|Southern Illinois University Neurology and Pharmacology, Springfield, Illinois, 62794-9643, United States|McFarland Clinic PC, Ames, Iowa, 50010-3014, United States|John Hopkins Hospital, Dept. of Neurology, Baltimore, Maryland, 21287, United States|Hattiesburg Clinic, Hattiesburg, Mississippi, 39401, United States|Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield, Missouri, 63017, United States|Dartmouth Medical School Neuroscience Center, Lebanon, New Hampshire, 03756-0001, United States|Five Towns Neuroscience Research, Cedarhurst, New York, 11516, United States|New York University Medical Centre, Comprehensive Epilepsy Center, New York, New York, 10016, United States|Weill Cornell Medical Center, Comprehensive Epilepsy Center, New York, New York, 10021, United States|Asheville Neurology Specialists, Asheville, North Carolina, 28806, United States|Ohio State University, Columbus, Ohio, 43210, United States|Medical University of Ohio at Toledo - Dept. of Neurology, Toledo, Ohio, United States|Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, 19104-4204, United States|University of Pennsylvania Medical Center-Department of Neurology, Philadelphia, Pennsylvania, 19104-4283, United States|University of Tennessee Health Sciences Center, Dept. of Neurology, Memphis, Tennessee, 38105, United States|Access Clinical Trials, Inc, Nashville, Tennessee, 37203, United States|Neurological Clinic of Texas, P.A., Dallas, Texas, 75230, United States|Texas Tech University Health Sciences Center, Dept. of Neuropsychiatry, El Paso, Texas, 79905, United States|Fletcher Allen Healthcare, Burlington, Vermont, 05401, United States Less <<
NCT04558580 Refractory Partial Seizures PHASE3 WITHDRAWN 2025-12-08 University of South Alabama, M... More >>obile, Alabama, 36693, United States Less <<
NCT03778424 Lennox Gastaut Syndrome AVAILABLE - Genera?a Tadeusza Ko?ciuszki 5... More >>2, Kielce, Poland|Szpital Kliniczny im. Heliodora ?wi?cickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu, Poznań, Poland Less <<
NCT01151540 Lennox-Gastaut Syndrome PHASE3 COMPLETED 2025-08-13 Nagoyashi, Aichi, Japan|Matsuy... More >>ama, Ehime, Japan|Fukuoka-shi, Fukuoka, Japan|Hiroshima-shi, Hiroshima, Japan|Sapporo-shi, Hokkaido, Japan|Kobe-shi, Hyogo, Japan|Yokohama, Kanagawa, Japan|Goshi^shi, Kumamoto, Japan|Iwanuma-shi, Miyagi, Japan|Omura, Nagasaki, Japan|Nara-shi, Nara, Japan|Niigata-shi, Niigata, Japan|Yufu-shi, Oita, Japan|Neyagawa-shi, Osaka, Japan|Osaka-shi, Osaka, Japan|Suita-shi, Osaka, Japan|Moriyama-shi, Shiga, Japan|Shizuoka-shi, Shizuoka, Japan|Kodaira, Tokyo, Japan|Kokubunji-shi, Tokyo, Japan|Shinjuku, Tokyo, Japan|Toyoma-shi, Toyama, Japan|Okayama, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.20mL

0.84mL

0.42mL

20.99mL

4.20mL

2.10mL

41.98mL

8.40mL

4.20mL

References

 

Historical Records

Categories